TrialNeurogastroenterology and motility2025

Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS-D and IBS-M: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial.

O Kuzminska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.